62,734
edits
Changes
no edit summary
|-
| 2015 || || || Vaccine approval || The {{w|RTS,S/AS01}} (trade name Mosquirix) becomes the world's first licensed {{w|malaria vaccine}}. Approved for use by European regulators.<ref>{{cite web|title=Malaria vaccine gets 'green light'|url=http://www.bbc.com/news/health-33641939?ns_mchannel=social&ns_campaign=bbc_news&ns_source=google_plus&ns_linkname=news_central|website=bbc.com|accessdate=26 April 2018}}</ref> ||
|-
| 2015 || November 24 || || || "FDA approved new injectable influenza vaccine, Fluad, for use in people age 65 years and older"<ref>{{cite web |title=FDA Approves First Seasonal Influenza Vaccine Containing an Adjuvant |url=https://community.aafa.org/blog/fda-approves-first-seasonal-influenza-vaccine-containing-an-adjuvant |website=community.aafa.org |accessdate=2 June 2020}}</ref> ||
|-
| 2016 || January 14 || Haemophilus influenzae || Vaccine approval || "FDA approved Hiberix for full Hib vaccine series."<ref>{{cite web |title=Food and Drug Administration Approval for Use of Hiberix as a 3-Dose Primary Haemophilus Influenzae Type b (Hib) Vaccination Series |url=https://www.medscape.com/viewarticle/862684#:~:text=On%20January%2014%2C%202016%2C%20GlaxoSmithKline,%2C%204%2C%20and%206%20months. |website=medscape.com |accessdate=2 June 2020}}</ref> ||
